- Home
- OBIO vs NLOP Comparison
OBIO vs NLOP Comparison
Compare OBIO & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OBIO | NLOP |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 246.2M | 198.4M |
| IPO Year | 2020 | 2022 |
Fundamental Metrics
Financial Performance| Metric | OBIO | NLOP |
|---|---|---|
| Price | $4.51 | $12.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $14.25 | N/A |
| AVG Volume (30 Days) | 165.7K | ★ 192.8K |
| Earning Date | 05-11-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 56.82% |
| EPS Growth | ★ 33.13 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $33,482,000.00 | ★ $118,915,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.43 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 1169.22 | N/A |
| 52 Week Low | $2.20 | $11.24 |
| 52 Week High | $5.42 | $34.53 |
Technical Indicators
Market Signals| Indicator | OBIO | NLOP |
|---|---|---|
| Relative Strength Index (RSI) | 55.74 | 36.27 |
| Support Level | $4.02 | $11.24 |
| Resistance Level | $4.88 | $14.95 |
| Average True Range (ATR) | 0.24 | 0.32 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 59.49 | 21.62 |
Price Performance
Historical ComparisonAbout OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a Maryland real estate investment trust that, together with its consolidated subsidiaries, owns a diversified portfolio of office properties that are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its net leases generally specify a base rent with rent increases and require the tenant to pay substantially all costs associated with operating and maintaining the property. Its portfolio includes approximately 1.2 million square feet of Green-Certified Buildings, 2 LEED-certified buildings, and 1 BREEAM-certified building.